β-Cell Replacement Strategies: The Increasing Need for a “β-Cell Dogma”
Type 1 diabetes is an auto-immune disease resulting in the loss of pancreatic β-cells and, consequently, in chronic hyperglycemia. Insulin supplementation allows diabetic patients to control their glycaemia quite efficiently, but treated patients still display an overall shortened life expectancy an...
Main Authors: | Andhira Vieira, Noémie Druelle, Fabio Avolio, Tiziana Napolitano, Sergi Navarro-Sanz, Serena Silvano, Patrick Collombat |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-06-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fgene.2017.00075/full |
Similar Items
-
GABA signaling stimulates α-cell-mediated β-like cell neogenesis
by: Tiziana Napolitano, et al.
Published: (2017-05-01) -
Increased CD34 in pancreatic islet negatively predict islet β-cell decrease in type1 diabetes model
by: Shichen Huang, et al.
Published: (2022-11-01) -
Role of β‐cell autophagy in β‐cell physiology and the development of diabetes
by: Xaviera Riani Yasasilka, et al.
Published: (2024-06-01) -
β cell replacement therapy for the cure of diabetes
by: Joonyub Lee, et al.
Published: (2022-11-01) -
Meteorin-Like Ameliorates β Cell Function by Inhibiting β Cell Apoptosis of and Promoting β Cell Proliferation via Activating the WNT/β-Catenin Pathway
by: Wenchao Hu, et al.
Published: (2021-03-01)